SOMATULINE
Brand-level analytics aggregated across all owners and jurisdictions using this name.
Total filings
5
Live
5
Live %
100.0%
Distinct owners
3
Jurisdictions
5
Top NICE
5Pharmaceuticals
Owners Using This Brand Name
| # | Owner | Country | Filings |
|---|---|---|---|
| 1 | IPSEN PHARMA S.A.S. | FR | 2 |
| 2 | SOCIETE DE CONSEILS DE RECHERCHES ET D' APPLICATIONS SCIENTIFIQUES (S.C.R.A.S.). | FR | 1 |
| 3 | IPSEN PHARMA S.A.S | FR | 1 |
| 4 | ايبسن فارما أس.أيه.أس. | FR | 1 |
Geographic Coverage
Filing presence across major commercial IP offices. Color intensity is a log scale of filing count -- darker = more filings. Gaps may indicate expansion opportunities or unprotected markets.
Madrid Protocol (WIPO)
Less
More·Log scale
1 covered · 37 gaps · 38 target jurisdictions
Targets are major commercial IP offices. Gaps may indicate expansion opportunities or unprotected risk.
US○
United States
—
JP○
Japan
—
GB○
United Kingdom
—
IT○
Italy
—
TW○
Taiwan
—
EM○
European Union (EUIPO)
—
CN○
China
—
KR○
South Korea
—
HK○
Hong Kong
—
IN○
India
—
CA●
Canada
1
AU○
Australia
—
NZ○
New Zealand
—
DE○
Germany
—
FR○
France
—
ES○
Spain
—
CH○
Switzerland
—
NL○
Netherlands
—
BX○
Benelux
—
SE○
Sweden
—
NO○
Norway
—
PL○
Poland
—
TR○
Turkey
—
RU○
Russia
—
BR○
Brazil
—
MX○
Mexico
—
AR○
Argentina
—
AE○
United Arab Emirates
—
SA○
Saudi Arabia
—
IL○
Israel
—
ZA○
South Africa
—
SG○
Singapore
—
MY○
Malaysia
—
TH○
Thailand
—
ID○
Indonesia
—
PH○
Philippines
—
VN○
Vietnam
—
WO○
Madrid (WIPO)
—
By Jurisdiction
| Jurisdiction | Total | Live |
|---|---|---|
| TT | 1 | 1 |
| MM | 1 | 1 |
| BH | 1 | 1 |
| CA | 1 | 1 |
| LA | 1 | 1 |
Recent Filings
| Date | Owner | Status | NICE | App # |
|---|---|---|---|---|
| 2023-04-26 | Registered | 5 | MM/T/2020/013602 | |
| 2011-09-16 | Registered | 5 | TT/M/1/044313 | |
| 1999-10-24 | Registered | 5 | BH/T/1/026410 | |
| 1997-05-29 | Registered | — | 0846541 | |
| 1996-09-23 | Registered | 5 | 4970 |